ABSTRACT
INTRODUCTION
African swine fever virus (ASFV) is a large icosahedral deoxyribonucleic acid containing virus which replicates in the cytoplasm of infected cells [for reviews see (1 -3) ] and is classified as the only member of a separate virus family (4) . The pattern of ASFV gene expression is temporally regulated and early, early/late and late classes of induced proteins are synthesised in infected cells (5, 6) . In common with the poxviruses, a cytoplasmic site of viral replication necessitates that ASFV encode many of the enzymes required for mRNA transcription and DNA replication. Some of these enzymes are packaged into ASFV particles, such as a DNA topoisomerase (7) and those required for early gene expression such as a DNAdependent RNA polymerase (8) and mRNA capping, methylation and polyadenylating enzymes (9) . Other enzyme activities are induced in ASFV infected cells (3) . The genes encoding thymidine kinase (10) , both the large and small subunits of ribonucleotide reductase (11) and of a ubiquitin conjugating enzyme (12) , have so far been identified on the ASFV genome.
EMBL accession no. X65192
The sequence of vaccinia virus DNA ligase has been reported (13) and is the only mammalian virus-encoded DNA ligase identified until now. It was predicted that ASFV should also encode its own DNA ligase because of its cytoplasmic site of replication, and similar genome structure and mode of replication to poxviruses. DNA ligases join single strand breaks in double stranded DNA by catalyzing the formation of phosphodiester bonds and require a divalent metal ion and either ATP or NAD+ as co-factor. They play a major role in joining Okazaki fragments produced during lagging strand DNA synthesis, sealing nicks in repaired DNA and completing recombination events by joining 'crossed over' DNA strands (14, 15) .
This report describes the identification and primary structure of an African swine fever virus gene encoding a 419 amino acid polypeptide of predicted molecular weight 48 kD with amino acid sequence homology to DNA ligases. In addition, the gene is shown to encode a Mr 45 
MATERIALS AND METHODS
Nucleotide sequencing A 4.2 kb DNA fragment from within the Sall g fragment of the Malawi Lil 20/1 strain of ASFV was isolated from SalI/BamHI restricted bacteriophage lambda clone LMw16 (16) (fig 1) . This fragment was inserted into the bluescript SK+ plasmid (Stratagene) and digested with exonuclease IH and SI nuclease to obtain a nested set of deletions for nucleotide sequence analysis (17) . Double stranded DNA was sequenced using the M13 reverse primer (18) . The second strand was sequenced using 15-mer oligonucleotide primers determined from the first strand sequence, spaced approximately 200 nucleotides apart. The nucleotide sequence data were assembled into contiguous sequences using the programmes DBAUTO and DBUTIL (19 variation in size between the DNA ligases attributed to the highly variable length of the amino terminal region upstream of the active site (25) . In contrast the carboxy termini appear well conserved in length and sequence. The bacteriophage T3 enzyme comprises 346 amino acids and has a predicted molecular weight of 39 kD (26) whereas the human DNA ligase I is a 102 kD polypeptide comprising 919 amino acids (27) . Due to the highly variable nature of the N-terminal regions of the DNA ligases, companisons were carried out using both full length sequences and sequences extending towards the C-terminus from the predicted active site lysine. In panel (a) the source of the DNA ligase gene is indicated: ASFV, bacteriophage T3, T4, T6 and T7 (PT3 to PT7 respectively), vaccinia virus (VV), Saccharomyces cerevisiae (S. cer) and human DNA ligase I (Human) (13, (26) (27) (28) (29) (30) (31) . 
The amino acid sequences surrounding the active site lysine of DNA ligases from ASFV, human DNA ligase I (Human), S. pombe, S. cerevisiae, bacteriophage T3, T4, T6 and T17 (PT3 to PT7) and vaccinia virus (VV) are shown (13, (26) (27) (28) (29) (30) (31) (32) Amino acid residues identical between the ASFV sequence and one or both of the other DNA ligase sequences are highlighted in bold upper case (13, 29) . The conserved active site region leave the alignment is underlined. The 16 amino acid peptide conserved at the carboxy termini of vaccinia virus, yeast and human DNA ligase 1 (13, 27, 31, 32) is also underlined. maximum of 32 % with bacteriophage T4 DNA ligase when just the carboxy terminal amino acids downstream from the putative active site lysine are compared (table 1). The conservation of both the sequence at the carboxy termini of eukaryotic DNA ligases and the distance between this conserved carboxy terminal region and the active site lysine suggest that these features play an important role in the function of the enzyme (25) . Although the level of identity between the ASFV and other known DNA ligases is higher in the carboxy terminal region downstream from the active site lysine residue, the carboxy terminus of the putative ASFV DNA ligase is at least 44 amino acids shorter than the other DNA ligases in this region (table 1) and does not contain the highly conserved 16 amino acid sequence present in vaccinia virus, yeast and human DNA ligase I enzymes (figure 2) (13, 27, 31, 32) . This region is immunologically cross-reactive between vaccinia and mammalian cell DNA ligases (33) . The shorter length of the putative ASFV DNA ligase carboxy terminal region compared with other DNA ligases may indicate differences in enzyme function, specificity in DNA binding or in targeting of the enzyme within cells. In particular, cellular DNA ligases function in the nucleus, whereas the ASFV DNA ligase probably functions in the cytoplasm and therefore may not contain a nuclear targeting signal. However, the C-terminal conserved basic region is not sufficient to dictate nuclear localization in vaccinia virusinfected cells since the vaccinia DNA ligase which contains this region is located in cytoplasmic virus factories. Perhaps when removed from the context of a virus infection the vaccinia enzyme becomes partially nuclear and this might explain the ability of vaccinia virus DNA ligase to complement a yeast mutant (33) . The ASFV DNA ligase is the smallest eukaryotic DNA ligase yet identified and it remains possible that it may be more highly homologous to the as yet uncloned mammalian DNA ligases H and Im (34 upstream of the ASFV DNA ligase gene at positions -3 to -7 and -30 to -36 with respect to the ATG. It is possible that one or both of these regions may be analogous to a critical vaccinia virus early promoter region thought to be required for the binding of a transcription factor (35) . No homology with either the eukaryotic polyadenylation signal (AATAAA) or the vaccinia virus early termination signal (TTTTTNT) (38, 39) is apparent within the nucleotide sequence adjacent to the stop codon of the ASFV ligase gene.
The conservation of the active site lysine and surrounding sequences and the identification of a Mr 45 kD protein with AMP-binding activity in cytoplasmic extracts of ASFV infected cells is consistent with the DNA ligase being functional. The presence of an ASFV encoded DNA ligase was predicted (13) since ASFV replicates in the cytoplasm of infected cells. This enzyme may be involved in the replication, repair or recombination of viral DNA. Vaccinia virus DNA ligase is not essential for viral replication or recombination in vitro (40, 41) , although it does play an important role in vivo (33) , and DNA ligase negative virus has an increased sensitivity to DNA damaging agents in vitro.
Very little is known about the mechanism of ASFV DNA replication, which occurs in the cytoplasm approximately midway through the infection cycle. The genome structure of ASFV and poxviruses is similar and consists of linear double stranded DNA closed by terminal hairpin loops which are present in two forms that are inverted and complementary with respect to each other. Head to head concatameric forms of DNA are also found in both ASFV and vaccinia virus infected cells (42, 43) , and thus, it is probable that the mechanism of ASFV DNA replication is similar to that utilised by the poxviruses. Two basic models have been proposed for poxviral DNA replication (reviewed in 44) . The simplest model comprises unidirectional synthesis after a nick is introduced at one or both ends of the genome in the terminal hairpin(s) followed by self-priming at the free 3' ends. This mechanism does not require a DNA ligase, as a nicking-joining enzyme (45) is capable of creating and sealing the necessary breaks in the DNA. A second model suggests leading and lagging strand synthesis. After the introduction of nick(s) and self-priming at the hairpin termini, DNA synthesis would proceed along both DNA strands. Okazaki-like fragments formed on the lagging strand would then require joining by a DNA ligase. Since vaccinia virus DNA ligase is not essential for virus replication in tissue culture cells, the first of these mechanisms is more likely, unless the vaccinia enzyme is complemented by cellular DNA ligase I (33), or by the immunologically unrelated DNA ligase II or III (34) .
Genetic recombination between the genomes of orthopoxviruses is well documented (46) (47) (48) (49) and genetic recombination between capripoxviruses during natural transmission has been suggested (50) . Recombination between ASF viruses has also been demonstrated in vitro (51) , and therefore, it is possible that poxvirus and ASFV DNA ligases augment the generation of recombinant viruses in the field. A function for these DNA ligases in either DNA recombination or repair could denote an instrumental role in viral evolution.
